Croce C M
The Kimmel Cancer Center, Philadelphia, Pennsylvania 19107, USA.
Cancer Res. 1999 Apr 1;59(7 Suppl):1778s-1783s.
We have investigated the role of chromosomal translocations in the pathogenesis of human leukemias. The study of T-cell chronic lymphocytic leukemias and T-cell prolymphocytic leukemia has led to the identification of TCL1, a novel gene that is deregulated by translocations, t(14;14)(q11;q32), or inversions, inv(14)(q11;q32.1). Introduction of a human TCL1 gene juxtaposed to the Ick promoter into fertilized mouse eggs resulted in the development of transgenic mice that developed mature T-cell leukemias, indicating that TCL1 is a transforming oncogene. We have also investigated acute leukemias with abnormalities at chromosome 11q23. We have identified a gene, ALL1, that can fuse to many different genes in acute leukemias. We have also shown that ALL1 can fuse with ALL1 in acute myelogenous leukemia. We have proposed that the ALL1 fusion genes may act by a dominant negative mechanism.
我们研究了染色体易位在人类白血病发病机制中的作用。对T细胞慢性淋巴细胞白血病和T细胞幼淋巴细胞白血病的研究已导致TCL1的鉴定,TCL1是一种新基因,它因易位t(14;14)(q11;q32)或倒位inv(14)(q11;q32.1)而失调。将与Ick启动子并列的人类TCL1基因导入受精小鼠卵中,导致了发育成成熟T细胞白血病的转基因小鼠的产生,这表明TCL1是一种转化癌基因。我们还研究了11q23染色体异常的急性白血病。我们鉴定出一个基因ALL1,它在急性白血病中可与许多不同基因融合。我们还表明,在急性髓性白血病中ALL1可与ALL1融合。我们提出ALL1融合基因可能通过显性负性机制起作用。